The scientific and ethical communities have long agreed against genetically modifying humans due to safety concerns. However, a researcher unexpectedly and prematurely performed such alterations on infants, sparking ethical controversies. The genetic changes aimed to strengthen immunity against potential future diseases rather than treating existing genetic conditions, a practice that resembles genetic enhancement. Gene editing technology carries the risk of unintended off-target effects, potentially causing new genetic diseases in otherwise healthy individuals.
In this specific case, the parents’ informed consent and external ethical oversight were questionable. As a result, there’s widespread concern about the safety of the modified infants and the potential backlash the technology could face, despite its promise in developing gene therapies for serious genetic conditions.
These ethical concerns should not undermine the value of the technology. Further research is needed to address the safety issues. However, it’s crucial to conduct such research ethically, taking into account the long-term implications of human germline editing and actively involving scientists, ethicists, policymakers, and the public in shaping guidelines for its usage.